AGC Biologics plant Erweiterung der biopharmazeutischen CDMO-Kapazität ...Middle East

Verdoppelung der Produktionskapazität an seinem Standort in Dänemark, um der starken Nachfrage gerecht zu werden SEATTLE, 2. Dezember 2020 /PRNewswire/ -- AGC Biologics gab bekannt, es werde die Produktionskapazität seines Werks in Kopenhagen erweitern. AGC Biologics wird ein neues...

Hence then, the article about agc biologics plant erweiterung der biopharmazeutischen cdmo kapazitat was published today ( Wednesday 02/12/2020 - 07:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AGC Biologics plant Erweiterung der biopharmazeutischen CDMO-Kapazität )

Also on site :

• GCE Global Solutions Corp. Announces Strategic Acquisition of GCE Payroll Advisers Inc. to Strengthen Global EOR and Payroll Platform
• Trump Wants To”Unleash Hell” In 2026; POTUS Tries To Go Full Maximus With A Misguided ‘Gladiator’ Flex
• Parents of Campbell Hall student killed in the school’s parking lot file wrongful death suit